Rankings
Publications
Sources
Publishers
Scholars
Organizations
About
Login
Register
Home
Publications
Prophylaxe ab dem ersten Schub: Satralizumab bei NMOSD zugelassen
Home
Publications
Prophylaxe ab dem ersten Schub: Satralizumab bei NMOSD zugelassen
Prophylaxe ab dem ersten Schub: Satralizumab bei NMOSD zugelassen
KB
Katharina Brüggen
Katharina Brüggen
Publisher Website
Google Scholar
Cite
Download
Share
Download
19 October 2021
journal article
Published by
Springer Science and Business Media LLC
in
NeuroTransmitter
Vol. 32
(10)
,
72
https://doi.org/10.1007/s15016-021-9274-7
Abstract
No abstract available